drugset / Trial / NCT05061641

Prediction and Prevention of Twin Premature Birth 2021

NCT05061641

Phase 4 Unknown 300 enrolled Caixia Liu
RandomizedParallel-groupDouble-blindTreatment

Summary

Research Objectives: 1. Establish a prediction and scoring system for twin premature birth. 2. To investigate the curative effect of 200mg,400mg and 600mg of vaginal progesterone in the prevention of twin premature birth. 3. To investigate the effect of stress cervical ligation in preventing premature delivery of twins. 4. The optimal dose of atosiban for the treatment of twin premature birth. 5. The influence of delivery mode on twin premature infants under 32 weeks.

Timeline

Start
2021-05-01
Primary completion
2022-06-01
Completion
2022-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 200 mg Other
Subject Progesterone Other / unclassified 400 mg Other
Subject Progesterone Other / unclassified 600 mg Other

Indications

No indication recorded.